Overview

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
To investigate the PK charateristics and the effect of food on the PK in healthy male volunteers who receive HIP1402 capsule in fed versus fasted condition
Phase:
Phase 1
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited